Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Huber

Showing results (1071-1080 of 1,120) with videos related to

Pageof 112
Sort By:
BMC Public Health|January 24, 2014
Behavioral and technological interventions targeting glycemic control in a racially/ethnically diverse population: a randomized controlled trialSamuel N Forjuoh, Jane N Bolin, John C Huber, et al.
Medical Care|June 1, 1997
Physicians' judgments of the risks of cardiac procedures. Differences between cardiologists and other internistsR M Poses, D K McClish, W R Smith, et al.
Nature Communications|January 26, 2022
Immunoglobulin signature predicts risk of post-acute COVID-19 syndromeCarlo Cervia, Yves Zurbuchen, Patrick Taeschler, et al.
Gynakologisch-Geburtshilfliche Rundschau|July 11, 1998
[The role of nitric oxide in reproduction]W Tschugguel, C Schneeberger, G Unfried, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|May 30, 2013
Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defectsMayura U Shinde, Ann M Vuong, Jean D Brender, et al.
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Journal of Medical Virology|July 3, 2023
A fully human monoclonal antibody possesses antibody-dependent cellular cytotoxicity (ADCC) activity against the H1 subtype of influenza A virus by targeting a conserved epitope at the HA1 protomer interfaceRongyuan Gao, Zhao Wang, Tirth Uprety, et al.
Plos One|June 11, 2015
Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype VirusesKara McCormick, Zhiyong Jiang, Longchao Zhu, et al.
Allergy|April 22, 2021
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19Sarah Adamo, Stéphane Chevrier, Carlo Cervia, et al.
American Journal of Epidemiology|March 9, 2016
Prenatal Exposure to Nitrosatable Drugs, Dietary Intake of Nitrites, and Preterm BirthAnn M Vuong, Mayura U Shinde, Jean D Brender, et al.
Pageof 112

Showing results (1071-1080 of 1,120) with videos related to

Sort By:
Pageof 112
BMC Public Health|January 24, 2014
Behavioral and technological interventions targeting glycemic control in a racially/ethnically diverse population: a randomized controlled trialSamuel N Forjuoh, Jane N Bolin, John C Huber, et al.
Medical Care|June 1, 1997
Physicians' judgments of the risks of cardiac procedures. Differences between cardiologists and other internistsR M Poses, D K McClish, W R Smith, et al.
Nature Communications|January 26, 2022
Immunoglobulin signature predicts risk of post-acute COVID-19 syndromeCarlo Cervia, Yves Zurbuchen, Patrick Taeschler, et al.
Gynakologisch-Geburtshilfliche Rundschau|July 11, 1998
[The role of nitric oxide in reproduction]W Tschugguel, C Schneeberger, G Unfried, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|May 30, 2013
Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defectsMayura U Shinde, Ann M Vuong, Jean D Brender, et al.
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Journal of Medical Virology|July 3, 2023
A fully human monoclonal antibody possesses antibody-dependent cellular cytotoxicity (ADCC) activity against the H1 subtype of influenza A virus by targeting a conserved epitope at the HA1 protomer interfaceRongyuan Gao, Zhao Wang, Tirth Uprety, et al.
Plos One|June 11, 2015
Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype VirusesKara McCormick, Zhiyong Jiang, Longchao Zhu, et al.
Allergy|April 22, 2021
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19Sarah Adamo, Stéphane Chevrier, Carlo Cervia, et al.
American Journal of Epidemiology|March 9, 2016
Prenatal Exposure to Nitrosatable Drugs, Dietary Intake of Nitrites, and Preterm BirthAnn M Vuong, Mayura U Shinde, Jean D Brender, et al.
Pageof 112